Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease
- Study Title
- A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease
- Teva Identifier
- TVP-1012/PM101
- ClinicalTrials.gov Identifier
- NCT00399477
- Study Status
- Completed
- Trial Condition(s)
- Parkinson's Disease
- Interventions
- Drug: rasagiline mesylate |Drug: Rasagiline mesylate plus Mirapex | Drug: Rasagiline mesylate with Levodopa | Drug: Rasagiline mesylate with Requip
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 30 Years and older
- Trial Duration
- 10/01/2006 - 07/01/2007
- Phase
- Phase 4